crainalerts

Jun 27, 2024, 04:06 PM UTC

AbbVie buys Celsius Therapeutics for $250 million

Having trouble viewing this email? See the online version Health Pulse Breaking News Thursday, June 27, 2024 Sign outside of AbbVie's North Chicago headquarters AbbVie buys drug developer Celsius

AbbVie buys Celsius Therapeutics for 0 million

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Thursday, June 27, 2024
Sign outside of AbbVie's North Chicago headquarters

AbbVie buys drug developer Celsius Therapeutics for $250 million

AbbVie is counting on the Cambridge-based biotech to further beef up its arsenal of drugs to fight Crohn's disease and ulcerative colitis.

 
Read More >

Did someone forward this to you? Sign up for Health Pulse breaking news alerts here and unlock access to the full story with a Health Pulse subscription.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

VIEW OUR SUBSCRIPTION OFFERS
 

This email was sent to -
Manage My Account | Contact Us

 

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

 

Latest Emails from crainalerts

See more